References
- DewingKAManagement of patients with psoriatic arthritisNurse Pract20154044046
- LiuJTYehHMLiuSYChenKTPsoriatic arthritis: epidemiology, diagnosis, and treatmentWorld J Orthop20145453725232529
- OgdieAWeissPThe epidemiology of psoriatic arthritisRheum Dis Clin North Am201541454556826476218
- De AngelisRSalaffiFGrassiWPrevalence of spondyloarthropathies in an Italian population sample: a regional community-based studyScand J Rheumatol2007361142117454930
- RamiroSSmolenJSLandewéRPharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritisAnn Rheum Dis201675349049826660203
- CoatesLCKavanaughAMeasePJGroup for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis: GRAPPA treatment recommendations for PsAArthritis Rheumatol20166851060107126749174
- CantiniFNiccoliLNanniniCTailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritisSemin Arthritis Rheum201645551953226607440
- GossecLSmolenJSRamiroSEuropean League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 updateAnn Rheum Dis201675349951026644232
- GossecLSmolenJSGaujoux-VialaCEuropean League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapiesAnn Rheum Dis201271141221953336
- LeeSMendelsohnASarnesEThe burden of psoriatic arthritis: a literature review from a global health systems perspectiveP T20103568068921197266
- Agenzia Italiana del Farmaco (AIFA)Guideline for the classification and conduction of the observational studies on medicines2010 Available from: https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_wysiwyg/files/CIRCULARS/Circular%2031st%20May%202010.pdf
- GonnellaJSLouisDZGozumMVCallahanCABarnesCADisease Staging Clinical and Coded Criteria (Version 5.26)Ann Arbor, MI, USAThomson Medstat2010
- Opinion 05/2014 on Privacy and Data Protection Available from: http://ec.europa.eu/justice/data-protection/article-29/documentation/opinion-recommendation/files/2014/wp216_it.pdf
- OlivieriIde PortuSSalvaraniCThe psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapyRheumatology200847111664167018725374
- KristensenLEJørgensenTSChristensenRSocietal costs and patients’ experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort studyAnn Rheum Dis20177691495150128137915
- BarraLPopeJEPayneMReal-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaireJ Rheumatol20093671421142819487267
- KavanaughAHelliwellPRitchlinCTPsoriatic arthritis and burden of disease: patient perspectives from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) surveyRheumatol Ther2016319110227747516
- TillettWde-VriesCMcHughNJWork disability in psoriatic arthritis: a systematic reviewRheumatology201251227528321752872
- Burgos-PolRMartínez-SesmeroJMVentura-CerdáJMElíasICalotoMTCasadoMÁThe cost of psoriasis and psoriatic arthritis in 5 European countries: a systematic reviewActas Dermosifiliogr2016107757759027316590
- LubranoESpadaroAPharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studiesBMC Musculoskelet Disord2014152524444003
- ChandranVGladmanDDUpdate on biomarkers in psoriatic arthritisCurr Rheumatol Rep201012428829420437120
- PriceKFRI0499 Real-world study on the patterns and cost of treatment failure in patients with psoriatic arthritis using us claims data in 677.2–677BMJ Publishing Group Ltd and European League Against Rheumatism201776Suppl 2677.2677